205 related articles for article (PubMed ID: 17915953)
21. Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase.
Kutty RK; Daniel RF; Ryan DE; Levin W; Maines MD
Arch Biochem Biophys; 1988 Feb; 260(2):638-44. PubMed ID: 3124760
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase.
Higashimoto Y; Sugishima M; Sato H; Sakamoto H; Fukuyama K; Palmer G; Noguchi M
Biochem Biophys Res Commun; 2008 Mar; 367(4):852-8. PubMed ID: 18194664
[TBL] [Abstract][Full Text] [Related]
23. Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase.
Pandey AV; Flück CE; Mullis PE
Biochem Biophys Res Commun; 2010 Sep; 400(3):374-8. PubMed ID: 20732302
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of heme oxygenase-1 from cyanobacterium Synechocystis sp. PCC 6803 in complex with heme.
Sugishima M; Migita CT; Zhang X; Yoshida T; Fukuyama K
Eur J Biochem; 2004 Nov; 271(22):4517-25. PubMed ID: 15560792
[TBL] [Abstract][Full Text] [Related]
25. Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase.
Sugishima M; Sato H; Higashimoto Y; Harada J; Wada K; Fukuyama K; Noguchi M
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2524-9. PubMed ID: 24550278
[TBL] [Abstract][Full Text] [Related]
26. Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation.
Yoshinaga T; Sassa S; Kappas A
J Biol Chem; 1982 Jul; 257(13):7778-85. PubMed ID: 6806282
[TBL] [Abstract][Full Text] [Related]
27. Human heme oxygenase oxidation of 5- and 15-phenylhemes.
Wang J; Niemevz F; Lad L; Huang L; Alvarez DE; Buldain G; Poulos TL; de Montellano PR
J Biol Chem; 2004 Oct; 279(41):42593-604. PubMed ID: 15297453
[TBL] [Abstract][Full Text] [Related]
28. Expression of heme oxygenase in hemopoiesis.
Abraham NG; Mitrione SM; Hodgson WJ; Levere RD; Shibahara S
Adv Exp Med Biol; 1988; 241():97-116. PubMed ID: 3146908
[TBL] [Abstract][Full Text] [Related]
29. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
Bonina TA; Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
[TBL] [Abstract][Full Text] [Related]
30. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs.
Quan S; Yang L; Abraham NG; Kappas A
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12203-8. PubMed ID: 11593038
[TBL] [Abstract][Full Text] [Related]
31. Regiospecificity determinants of human heme oxygenase: differential NADPH- and ascorbate-dependent heme cleavage by the R183E mutant.
Wang J; Lad L; Poulos TL; Ortiz de Montellano PR
J Biol Chem; 2005 Jan; 280(4):2797-806. PubMed ID: 15525643
[TBL] [Abstract][Full Text] [Related]
32. Rat liver heme oxygenase. High level expression of a truncated soluble form and nature of the meso-hydroxylating species.
Wilks A; Ortiz de Montellano PR
J Biol Chem; 1993 Oct; 268(30):22357-62. PubMed ID: 8226746
[TBL] [Abstract][Full Text] [Related]
33. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
Reed JR; Huber WJ; Backes WL
Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
[TBL] [Abstract][Full Text] [Related]
34. Expression of rat heme oxygenase in Escherichia coli as a catalytically active, full-length form that binds to bacterial membranes.
Ishikawa K; Sato M; Yoshida T
Eur J Biochem; 1991 Nov; 202(1):161-5. PubMed ID: 1935972
[TBL] [Abstract][Full Text] [Related]
35. Caveolin-1 is a competitive inhibitor of heme oxygenase-1 (HO-1) with heme: identification of a minimum sequence in caveolin-1 for binding to HO-1.
Taira J; Sugishima M; Kida Y; Oda E; Noguchi M; Higashimoto Y
Biochemistry; 2011 Aug; 50(32):6824-31. PubMed ID: 21721581
[TBL] [Abstract][Full Text] [Related]
36. Demonstration that histidine 25, but not 132, is the axial heme ligand in rat heme oxygenase-1.
Ito-Maki M; Ishikawa K; Matera KM; Sato M; Ikeda-Saito M; Yoshida T
Arch Biochem Biophys; 1995 Feb; 317(1):253-8. PubMed ID: 7872792
[TBL] [Abstract][Full Text] [Related]
37. The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase. Electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN.
Higashimoto Y; Sato H; Sakamoto H; Takahashi K; Palmer G; Noguchi M
J Biol Chem; 2006 Oct; 281(42):31659-67. PubMed ID: 16928691
[TBL] [Abstract][Full Text] [Related]
38. Crystallization of recombinant human heme oxygenase-1.
Schuller DJ; Wilks A; Ortiz de Montellano P; Poulos TL
Protein Sci; 1998 Aug; 7(8):1836-8. PubMed ID: 10082382
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
40. Resolution of the rat brain heme oxygenase activity: absence of a detectable amount of the inducible form (HO-1).
Trakshel GM; Kutty RK; Maines MD
Arch Biochem Biophys; 1988 Feb; 260(2):732-9. PubMed ID: 3124761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
